GLP-1s Are Not Just a Weight Loss Story
GLP-1 medications are being studied for effects that may extend beyond weight loss, including cardiometabolic outcomes and behavior-related pathways.
18 min readRead->
Medicine
Tirzepatide
Consumer health intelligence on tirzepatide, obesity medicine, sleep apnea data, maintenance, and safety.
1 published articleBuilding this topic
Related research
SURMOUNT-1: Tirzepatide once weekly for the treatment of obesitySURMOUNT-3: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesitySURMOUNT-4: Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesitySURMOUNT-OSA: Tirzepatide for the treatment of obstructive sleep apnea and obesitySURMOUNT-MMO: SURMOUNT-MMO: tirzepatide and morbidity/mortality in obesity
Useful source library entries
FDA approves Zepbound as first medication for obstructive sleep apnea in adults with obesityFDA clarifies policies for compounders as GLP-1 supply stabilizesZepbound prescribing informationTirzepatide once weekly for the treatment of obesityTirzepatide after intensive lifestyle intervention in adults with overweight or obesity
Related topics
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No miracle claims. Just better health signal.
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No miracle claims. Just better health signal.